Quinolones: Difference between revisions

From EcoliWiki
Jump to navigation Jump to search
Jtownley (talk | contribs)
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==About==  
==Targets==
Binds to Topoisomerase IV and DNA Gyrase to form poisonous adducts on the DNA.
Type II Topoisomerases
*DNA Gyrase
*Topoisomerase IV<ref name='PMID:8524852'/>
**inhibition by norfloxacin reduces activity to a rate of 1/100 the normal level<ref name='PMID:7590259'/>
 
 
Results in replication fork collapse and induction of the SOS response due to permanent double-stranded breaks caused by the formation of poisonous protein:DNA adducts.
 
==Resistant Alleles==
*ParC


==Usage Examples and Notes==
==Usage Examples and Notes==
*Norfloxacin<ref name='PMID:16164551'/>
*Norfloxacin<ref name='PMID:16164551'/>
*Oxolinic acid and nalidixic acid interact with the same target to inhibit replication DNA synthesis. Although nalidixic acid is used extensively, oxolinic acid has ben found to be 10-fold more active of an inhibitor. Mutants with resistance to one drug also show resistance to the other drug. <ref name='PMID:770163'/>


== References ==
== References ==

Latest revision as of 16:04, 1 October 2013

Targets

Type II Topoisomerases

  • DNA Gyrase
  • Topoisomerase IV[1]
    • inhibition by norfloxacin reduces activity to a rate of 1/100 the normal level[2]


Results in replication fork collapse and induction of the SOS response due to permanent double-stranded breaks caused by the formation of poisonous protein:DNA adducts.

Resistant Alleles

  • ParC

Usage Examples and Notes

  • Norfloxacin[3]
  • Oxolinic acid and nalidixic acid interact with the same target to inhibit replication DNA synthesis. Although nalidixic acid is used extensively, oxolinic acid has ben found to be 10-fold more active of an inhibitor. Mutants with resistance to one drug also show resistance to the other drug. [4]

References

See Help:References for how to manage references in EcoliWiki.

  1. ↑ Khodursky, AB et al. (1995) Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 92 11801-5 PubMed
  2. ↑ Zechiedrich, EL & Cozzarelli, NR (1995) Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli. Genes Dev. 9 2859-69 PubMed
  3. ↑ Lopez, CR et al. (2005) A role for topoisomerase III in a recombination pathway alternative to RuvABC. Mol. Microbiol. 58 80-101 PubMed
  4. ↑ Staudenbauer, WL (1976) Replication of Escherichia coli DNA in vitro: inhibition by oxolinic acid. Eur. J. Biochem. 62 491-7 PubMed